TSO3 SENDS ADDED INFO ON FDA REQUEST

摘要

TSO3, an innovator in sterilisation technology for medical devices in healthcare settings in Canada, has submitted its response to the US Regulatory Authorities request for Additional Information. The response allows the Regulatory Authorities to continue its review for market clearance of the TSO3 Sterizone VP4 Steriliser in the US. The submission is for a product similar to the Sterizone 125L+ steriliser cleared in Canada and Europe yet with improved claims for the US market.